Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

The role of complement in antibody mediated transplant rejection.

Thurman JM, Panzer SE, Le Quintrec M.

Mol Immunol. 2019 Aug;112:240-246. doi: 10.1016/j.molimm.2019.06.002. Epub 2019 Jun 10. Review.

PMID:
31195225
3.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.

Kidney Int. 2019 Jun;95(6):1443-1452. doi: 10.1016/j.kint.2019.01.023. Epub 2019 Mar 15.

PMID:
30982675
4.

C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.

Goutaudier V, Perrochia H, Mucha S, Bonnet M, Delmas S, Garo F, Garrigue V, Lepreux S, Pernin V, Serre JE, Szwarc I, Merville P, Ramounau-Pigot A, René C, Visentin J, Morgan BP, Frémeaux-Bacchi V, Mourad G, Couzi L, Le Quintrec M.

Front Immunol. 2019 Mar 8;10:235. doi: 10.3389/fimmu.2019.00235. eCollection 2019.

5.

Successful treatment of a Streptococcus pneumoniae-associated haemolytic uraemic syndrome by eculizumab.

Jeantet G, Pernin V, Brunot V, Roccabianca A, Macombe A, Szwarc I, Klouche K, Loirat C, Mourad G, Frémeaux-Bacchi V, Le Quintrec M.

Clin Kidney J. 2019 Feb;12(1):106-109. doi: 10.1093/ckj/sfy019. Epub 2018 Mar 20.

6.

Endothelium structure and function in kidney health and disease.

Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT.

Nat Rev Nephrol. 2019 Feb;15(2):87-108. doi: 10.1038/s41581-018-0098-z. Review.

PMID:
30607032
7.

"Neuro-renal syndrome" related to anti-contactin-1 antibodies.

Taieb G, Le Quintrec M, Pialot A, Szwarc I, Perrochia H, Labauge P, Devaux JJ.

Muscle Nerve. 2019 Mar;59(3):E19-E21. doi: 10.1002/mus.26392. Epub 2019 Jan 6. No abstract available.

PMID:
30488516
8.

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.

Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, Delmas Y, Le Quintrec M, Guerrot D, Jourde-Chiche N, Ribes D, Ronco P, Bridoux F, Fremeaux-Bacchi V.

Front Immunol. 2018 Oct 2;9:2260. doi: 10.3389/fimmu.2018.02260. eCollection 2018.

9.

In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'.

Le Quintrec M, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Dec;72(6):906-907. doi: 10.1053/j.ajkd.2018.08.005. Epub 2018 Sep 17. No abstract available.

PMID:
30236629
10.

Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients.

Souweine JS, Kuster N, Chenine L, Rodriguez A, Patrier L, Morena M, Badia E, Chalabi L, Raynal N, Ohresser I, Leray-Moragues H, Mercier J, Hayot M, Le Quintrec M, Gouzi F, Cristol JP.

PLoS One. 2018 Aug 1;13(8):e0200061. doi: 10.1371/journal.pone.0200061. eCollection 2018.

11.

Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.

Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, Christians U, Klawitter J, Lindorfer MA, Taylor RP, Holers VM, Thurman JM.

J Am Heart Assoc. 2018 Jul 13;7(14). pii: e007818. doi: 10.1161/JAHA.117.007818.

12.

Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report.

Deshayes S, Martin Silva N, Chatelet V, Chantepie S, Le Quintrec M, Comoz F, Bridoux F, Dragon-Durey MA, Aouba A.

Clin Rheumatol. 2018 Apr;37(4):1119-1122. doi: 10.1007/s10067-018-4058-6. Epub 2018 Mar 7. Review.

PMID:
29516279
13.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.

PMID:
29429752
14.

Stricturing Crohn's disease-like colitis in a patient treated with belatacept.

Bozon A, Jeantet G, Rivière B, Funakoshi N, Dufour G, Combes R, Valats JC, Delmas S, Serre JE, Bismuth M, Ramos J, Le Quintrec M, Blanc P, Pineton de Chambrun G.

World J Gastroenterol. 2017 Dec 28;23(48):8660-8665. doi: 10.3748/wjg.v23.i48.8660.

15.

Correction: Consequences of increasing convection onto patient care and protein removal in hemodialysis.

Gayrard N, Ficheux A, Duranton F, Guzman C, Szwarc I, Vetromile F, Cazevieille C, Brunet P, Servel MF, Argilés À, Le Quintrec M.

PLoS One. 2018 Jan 2;13(1):e0190761. doi: 10.1371/journal.pone.0190761. eCollection 2018.

16.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
17.

A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.

Togarsimalemath SK, Sethi SK, Duggal R, Le Quintrec M, Jha P, Daniel R, Gonnet F, Bansal S, Roumenina LT, Fremeaux-Bacchi V, Kher V, Dragon-Durey MA.

Kidney Int. 2017 Oct;92(4):876-887. doi: 10.1016/j.kint.2017.04.025. Epub 2017 Jul 18.

PMID:
28729035
18.

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.

Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V.

Kidney Int. 2017 Nov;92(5):1232-1241. doi: 10.1016/j.kint.2017.04.017. Epub 2017 Jul 14.

PMID:
28712854
19.

Consequences of increasing convection onto patient care and protein removal in hemodialysis.

Gayrard N, Ficheux A, Duranton F, Guzman C, Szwarc I, Vetromile F, Cazevieille C, Brunet P, Servel MF, Argilés À, Le Quintrec M.

PLoS One. 2017 Feb 6;12(2):e0171179. doi: 10.1371/journal.pone.0171179. eCollection 2017. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190761.

20.

Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.

Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J, Frimat M, Ulinski T, Deschênes G, Burtey S, Delahousse M, Moulin B, Legendre C, Frémeaux-Bacchi V, Le Quintrec M.

J Am Soc Nephrol. 2017 May;28(5):1603-1613. doi: 10.1681/ASN.2016030343. Epub 2017 Jan 17.

21.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F.

Blood. 2017 Mar 16;129(11):1437-1447. doi: 10.1182/blood-2016-08-737163. Epub 2017 Jan 9.

PMID:
28069603
22.

[Infectious and neoplasic complications after kidney transplantation].

Mourad G, Serre JE, Alméras C, Basel O, Garrigue V, Pernin V, Le Quintrec M.

Nephrol Ther. 2016 Nov;12(6):468-487. doi: 10.1016/j.nephro.2016.06.003. Epub 2016 Sep 24. French.

PMID:
27686031
23.

Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method.

Bargnoux AS, Sutra T, Badiou S, Kuster N, Dupuy AM, Mourad G, Pageaux GP, Le Quintrec M, Cristol JP.

Ther Drug Monit. 2016 Dec;38(6):808-812.

PMID:
27494947
24.

Complement activation and effect of eculizumab in scleroderma renal crisis.

Devresse A, Aydin S, Le Quintrec M, Demoulin N, Stordeur P, Lambert C, Gastoldi S, Pirson Y, Jadoul M, Morelle J.

Medicine (Baltimore). 2016 Jul;95(30):e4459. doi: 10.1097/MD.0000000000004459.

25.

Targeting the complement cascade: novel treatments coming down the pike.

Thurman JM, Le Quintrec M.

Kidney Int. 2016 Oct;90(4):746-52. doi: 10.1016/j.kint.2016.04.018. Epub 2016 Jun 18. Review.

26.

Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Laskowski J, Renner B, Le Quintrec M, Panzer S, Hannan JP, Ljubanovic D, Ruseva MM, Borza DB, Antonioli AH, Pickering MC, Holers VM, Thurman JM.

Kidney Int. 2016 Jul;90(1):109-22. doi: 10.1016/j.kint.2016.02.036. Epub 2016 May 7.

27.

The Complement System and Antibody-Mediated Transplant Rejection.

Stites E, Le Quintrec M, Thurman JM.

J Immunol. 2015 Dec 15;195(12):5525-31. doi: 10.4049/jimmunol.1501686. Review.

28.

Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.

Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA.

J Immunol. 2015 Jun 1;194(11):5129-38. doi: 10.4049/jimmunol.1402770. Epub 2015 Apr 27.

29.

Eculizumab for treatment of rapidly progressive C3 glomerulopathy.

Le Quintrec M, Lionet A, Kandel C, Bourdon F, Gnemmi V, Colombat M, Goujon JM, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2015 Mar;65(3):484-9. doi: 10.1053/j.ajkd.2014.09.025. Epub 2014 Dec 17.

PMID:
25530108
30.

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.

Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C.

Semin Thromb Hemost. 2014 Jun;40(4):444-64. doi: 10.1055/s-0034-1376153. Epub 2014 Jun 9. Review.

PMID:
24911558
31.

Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.

Zuber J, Le Quintrec M, Morris H, Frémeaux-Bacchi V, Loirat C, Legendre C.

Transplant Rev (Orlando). 2013 Oct;27(4):117-25. doi: 10.1016/j.trre.2013.07.003. Epub 2013 Aug 12. Review.

PMID:
23937869
32.

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

Lemaire M, Frémeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nürnberg G, Altmüller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nürnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP.

Nat Genet. 2013 May;45(5):531-6. doi: 10.1038/ng.2590. Epub 2013 Mar 31.

33.

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Frémeaux-Bacchi V.

Am J Transplant. 2013 Mar;13(3):663-75. doi: 10.1111/ajt.12077. Epub 2013 Jan 28.

34.

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS.

Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7.

35.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

36.

Genetics of hemolytic uremic syndromes.

Malina M, Roumenina LT, Seeman T, Le Quintrec M, Dragon-Durey MA, Schaefer F, Fremeaux-Bacchi V.

Presse Med. 2012 Mar;41(3 Pt 2):e105-14. doi: 10.1016/j.lpm.2011.10.028. Epub 2012 Jan 20. Review.

PMID:
22265161
37.

1st EFIS-EJI intensive course in clinical immunology: towards a new era in immunology.

Cabon L, Chatterjee S, Delavallée L, Le Quintrec M, Maître M, Roumenina LT.

Eur J Immunol. 2011 Feb;41(2):268-9. doi: 10.1002/eji.201190002. No abstract available.

38.

New insights into postrenal transplant hemolytic uremic syndrome.

Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Frémeaux-Bacchi V, Legendre C.

Nat Rev Nephrol. 2011 Jan;7(1):23-35. doi: 10.1038/nrneph.2010.155. Epub 2010 Nov 23. Review.

PMID:
21102542
39.

Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.

Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, André JL, Takagi N, Cheong HI, Hari P, Le Quintrec M, Niaudet P, Loirat C, Fridman WH, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2010 Dec;21(12):2180-7. doi: 10.1681/ASN.2010030315. Epub 2010 Nov 4.

40.

Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.

Le Quintrec M, Roumenina L, Noris M, Frémeaux-Bacchi V.

Semin Thromb Hemost. 2010 Sep;36(6):641-52. doi: 10.1055/s-0030-1262886. Epub 2010 Sep 23. Review.

PMID:
20865641
41.

Fanconi syndrome due to deferasirox.

Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M.

Am J Kidney Dis. 2009 Nov;54(5):931-4. doi: 10.1053/j.ajkd.2009.03.013. Epub 2009 Jun 3.

PMID:
19493602
42.

Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.

Le Quintrec M, Zuber J, Noel LH, Thervet E, Frémeaux-Bacchi V, Niaudet P, Fridman WH, Legendre C, Dragon-Durey MA.

Am J Transplant. 2009 May;9(5):1223-9. doi: 10.1111/j.1600-6143.2009.02586.x. Erratum in: Am J Transplant. 2009 Sep;9(9):2205. Niauif, P [added]. Am J Transplant.2009 Nov;9(11):2647. Niauif, P [corrected to Niaudet, P].

43.

Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.

Le Quintrec M, Lionet A, Kamar N, Karras A, Barbier S, Buchler M, Fakhouri F, Provost F, Fridman WH, Thervet E, Legendre C, Zuber J, Frémeaux-Bacchi V.

Am J Transplant. 2008 Aug;8(8):1694-701. doi: 10.1111/j.1600-6143.2008.02297.x. Epub 2008 Jun 28.

44.

[Immunosuppression in kidney transplantation].

Legendre C, Zuber J, Anglicheau D, Le Quintrec M, Martinez F, Mamzer-Bruneel MF, Thervet E.

Ann Urol (Paris). 2007 Dec;41(6):276-84. Review. French.

PMID:
18457319
45.

Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.

El Karoui K, Le Quintrec M, Dekeyser E, Servais A, Hummel A, Fadel F, Fakhouri F.

Nephrol Dial Transplant. 2008 Feb;23(2):757-63. Epub 2007 Dec 1. Review. No abstract available.

PMID:
18056072
46.

Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study.

Anglicheau D, Loupy A, Suberbielle C, Zuber J, Patey N, Noël LH, Cavalcanti R, Le Quintrec M, Audat F, Méjean A, Martinez F, Mamzer-Bruneel MF, Thervet E, Legendre C.

Am J Transplant. 2007 May;7(5):1185-92. Epub 2007 Mar 12.

47.

Herbs and the kidney.

Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL.

Am J Kidney Dis. 2004 Jul;44(1):1-11. Review.

PMID:
15211432
48.

[Tuberculosis tonsillitis and otitis].

Le Quintrec M, Mortier E, Vinceneux P, Pouchot J.

Presse Med. 2001 Jan 20;30(2):62. French. No abstract available.

PMID:
11244812
49.

Adaptive hyperphagia in patients with postsurgical malabsorption.

Cosnes J, Lamy P, Beaugerie L, Le Quintrec M, Gendre JP, Le Quintrec Y.

Gastroenterology. 1990 Dec;99(6):1814-9.

PMID:
2227296
50.

[Elemental feeding into the distal segment of a temporary small bowel].

Cosnes J, Baux F, Gendre JP, Le Quintrec M, Frileux P, Parc R, Le Quintrec Y.

Gastroenterol Clin Biol. 1990;14(2):146-52. French.

PMID:
2109716

Supplemental Content

Loading ...
Support Center